ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1377	National Cancer Institute	Html	en	Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for ovarian, fallopian tube, and primary peritoneal cancers.	ovarian cancer incidence 0.485939 PLCO trial participants 0.376238 annual CA-125 concentrations 0.379685 control group 0.373899 TVU 0.416096 intervention group 0.456353 ovarian cancer mortality 0.605058 usual-care group 0.519997 ovarian cancer. 0.438341 simultaneous screening 0.374743 multimodality screening 0.410213 ovarian cancer patients 0.493657 Ovarian Cancer Screening 0.521015 multimodality screening arm 0.400746 term ovarian cancer 0.514244 ovarian screening intervention 0.52207 Ovarian cancer diagnoses 0.474885 positive screening test 0.421138 ovarian cancer 0.995711 ovarian origin 0.452276 screening group 0.412155 PLCO trial 0.50373 screening centers 0.380449 Single-threshold CA-125 levels 0.385265	CA-125 reference value 0.384378 multimodal screening 0.42795 women 0.438262 screening test results 0.415787 low-grade serous carcinomas. 0.372717 ovarian cancers 0.495247 mortality rate ratio 0.417901 CA-125 concentrations 0.454756 screening protocol 0.374983 CA-125 levels 0.452675 incident ovarian cancers 0.460255 concurrent bulky carcinomas 0.374346 annual screening 0.391284 statistically nonsignificant mortality 0.377585 regular screening attendees 0.399753 ovarian volume increases 0.454792 high-grade serous carcinoma 0.426123 Shizuoka Cancer Registry 0.385833 epithelial ovarian carcinomas. 0.474733 cancer case treatment 0.383697 single-threshold CA-125 concentrations 0.37905 stage 0.375125 Elevated CA-125 levels 0.386511 Cancer Screening Trial 0.444611	CLICK HERE
1781	National Cancer Institute	Html	es	Aflicción, duelo y manejo de la pérdida (PDQ®)–Versión para profesionales de salud	Informe revisado por expertos acerca de la aflicción, el duelo y los sentimientos de pérdida de los sobrevivientes de alguien que murió de cáncer. Se trata también la aflicción en los niños.	stage theory 0.267105 Maciejewski PK 0.231481 Stroebe MS 0.59893 Stroebe W 0.357559 Life after death 0.262032 recovery from bereavement 0.268449 practical approach 0.234785 Prigerson HG 0.312593 American Psychiatric 0.266127 querido experimentarán 0.250079 American Psychological Association 0.813443 anticipatory grief 0.242932 Basic Books 0.301434 doctors just suddenly 0.262469 expresión aflicción 0.53581 of bereavement 0.95448 Clin Psychol 0.275517 author reply 0.229064 Weiss RS 0.256177 OF BEREAVEMENT REACTIONS 0.235244 Abrahm J 0.230792 post-traumatic stress disorder 0.252503 normal grief 0.23971 Bonanno GA 0.370739 Rando TA 0.231119	aflicción crónica 0.899606 Psychol Rev 0.235309 hombres media 0.239089 aflicción —una estructura 0.407961 Kaltman S 0.233673 parkes cm 0.351633 Bowlby J 0.229028 stress disorder 0.261132 Publishing Company 0.2876 Kutner JS 0.233996 grief therapy 0.242395 Zisook S 0.24705 New York 0.577019 Pathologic Grief 0.292395 Intern Med 0.234619 Hansson RO 0.641388 Clin Psychiatry 0.231444 Volume III 0.230537 querido experimentarán períodos 0.229309 Springer Publishing Company 0.252277 BEREAVEMENT AND MENTAL 0.237671 Schut H 0.386829 Jacobs SC 0.300142 Casarett D 0.230099	CLICK HERE
1816	National Cancer Institute	Html	es	Tratamiento del glioma de tronco encefálico infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del glioma de tronco encefálico infantil.	gliomas highlights platelet-derived 0.0180248 encefálico infantiles recién 0.0174306 focal brainstem gliomas 0.0175295 brainstem tumors 0.0356739 mutación h3 k27m 0.0183362 activating acvr1 mutations 0.0269847 pediatric brain 0.0219051 glioma with 0.0184685 encefálico focales recidivantes 0.0176848 Radiat Oncol Biol 0.0940294 Pediatric Brain Tumor 0.0189297 mutación h3 0.0289221 diffuse brainstem glioma 0.0359565 brainstem gliomas 0.119063 central nervous system 0.0139993 recurrent activating acvr1 0.0274852 Nat Genet 0.0675122 intrinsic brain stem 0.0150908 patients with 0.025125 radiation therapy 0.0349088 intrinsic pontine glioma 0.946885 Acta Neuropathol 0.0426011 encefálico infantiles grupo 0.0167365 Broniscer A 0.0151338 intrinsic brainstem gliomas 0.0346829	Pediatric MATCH 0.0156687 encefálico focales recién 0.0279293 Neuro Oncol 0.0299682 with newly 0.0211799 brain stem gliomas 0.0552126 encefálico infantiles recidivantes 0.0293915 pediatric patients 0.0205505 low-grade glioma 0.0256326 Pediatr Blood Cancer 0.019874 intracranial low-grade gliomas 0.0165924 report from 0.0151672 tumores dipg 0.0243332 encefálico focales resección 0.0182395 Clin Oncol 0.0362551 Oncol Biol Phys 0.0989347 Zhou T 0.0230102 Neurosurg Pediatr 0.0180743 Pediatric Oncology Group 0.0173483 newly diagnosed 0.0303637 with neurofibromatosis 0.0165895 children's oncology group 0.138637 Acta Neuropathol Commun 0.0194776 Childs Nerv Syst 0.0434615 diffuse intrinsic pontine 0.990784	CLICK HERE
1921	National Cancer Institute	Html	es	Tratamiento del cáncer de piel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de piel.	almacena agua 0.377251 siguientes procedimientos 0.484494 Estadio IA 0.400496 estadio iv 0.835623 Estadio IC 0.400325 siguientes aspectos 0.39369 estadio ii 0.685519 Estadio IIIC 0.402008 estadios ia 0.349569 Estadio IIIA 0.403211 rayos x 0.363326 pulmón.ampliar cáncer 0.632928 menor cantidad 0.423989 luz solar 0.966967 Basal Cell Carcinoma 0.789488 vitamina d 0.373991 National Cancer Institute 0.332744	vitamina a 0.337818 siguientes riesgos 0.326866 pequeños carcinomas 0.336448 Instituto Nacional 0.361575 PDQ Tratamiento 0.358407 Drugs Approved 0.513635 Physician Data Query 0.424982 Cabello pelirrojo 0.519578 lápiz mide 0.408824 siguientes características 0.456672 cara.ampliar cirugía 0.345299 aspecto anormal.ampliar biopsia 0.448697 piel causa efectos 0.518422 panel derecho 0.432885 siguientes sumarios 0.432177 siguientes pruebas 0.387403	CLICK HERE
1941	National Cancer Institute	Html	es	La espiritualidad en el tratamiento del cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de la influencia que tiene la espiritualidad y la religión en las personas que tienen cáncer. Se discuten varios métodos sobre manejo e intervención.	Illness Therapy—Spiritual Well-Being 0.364147 Koenig HG 0.516168 with breast 0.448622 with medical care 0.377932 Coping with breast 0.377717 among patients with 0.376638 religious involvement 0.469162 coping with 0.537521 religious coping 0.832653 longitudinal study 0.375646 Natl Med Assoc 0.392743 psychological distress 0.369731 Spillers RL 0.367074 palliative care consultation 0.388149 Sin embargo 0.391017 Psychiatry Med 0.42361 spiritual needs 0.450941 Balboni TA 0.366785 satisfaction with care 0.45185 among persons with 0.418188 patients with 0.768654 Religious Coping Scale 0.480675 Pargament KI 0.627933 Larson DB 0.403043 Tarakeshwar N 0.414441	Olver IN 0.377185 Care Cancer 0.680736 palliative care 0.405966 meet spiritual needs 0.420651 spiritual well-being among 0.364926 Vanderwerker LC 0.413553 mortality among medically 0.373039 spiritual well-being 0.567991 Consult Clin Psychol 0.378631 New York 0.37969 Intern Med 0.421384 Spiritual Intervention Study 0.363114 Palliat Med 0.935675 Clin Oncol 0.573043 Spiritual Well-Being Scale 0.362892 Cancer Surviv 0.366225 Arch Intern Med 0.39787 with metastatic breast 0.403978 spirituality as predictors 0.390155 spiritual care 0.472279 ill elderly patients 0.379545 chronic illness 0.365965 spiritual support among 0.431243 associations with 0.43557	CLICK HERE
2030	National Cancer Institute	Html	es	Exámenes de detección del cáncer de seno (mama) (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de mama.	carcinoma in situ 0.428206 Surgical Adjuvant Breast 0.33856 Breast Screening Study-2 0.364743 cohort with breast 0.321173 Breast Cancer Surveillance 0.36101 American Cancer Society 0.380459 ductal proliferative breast 0.324288 ductal carcinoma in 0.430875 breast biopsy 0.352636 Elmore JG 0.344418 Swedish two-county breast 0.320934 Breast Screening 0.503535 Breast Screening Study 0.375642 Rosenberg RD 0.33024 Kerlikowske K 0.327142 Nelson HD 0.325559 Canadian National Breast 0.417726 Individual Breast Biopsy 0.343511 evaluación bi-rads 0.320008 Scotia Breast Screening 0.356932 breast pathology 0.332437 Estados Unidos 0.485991 screening mammograms 0.346351 Natl Cancer Inst 0.674282 Breast tumor characteristics 0.346186	mamografía detecta 0.320239 breast self-examination 0.321577 screening mammographic sensitivity 0.338051 National Breast Screening 0.456899 mamografía digital versus 0.325297 Breast Screening Program 0.356597 modern screening mammography 0.338726 Cancer Facts 0.328174 breast cancers 0.931042 Image-detected breast 0.320721 Breast Imaging Reporting 0.320397 screening mammography 0.509779 Breast Biopsy Slides 0.344265 screening trial 0.341724 mammographic screening 0.329483 Carney PA 0.325142 Intern Med 0.487403 Breast symptoms among 0.322392 Arch Intern Med 0.323503 clinical breast 0.339712 mammographic screening from 0.319885 in situ 0.62536 Cancer Surveillance Consortium 0.332496 Nova Scotia Breast 0.339428	CLICK HERE
2075	National Cancer Institute	Html	es	Cánceres de cabeza y cuello	Hoja informativa acerca de los factores de riesgo, síntomas, diagnóstico, tratamiento, seguimiento y rehabilitación por los cánceres de cabeza y cuello.	Neck Cancer Epidemiology 0.358567 3rd ed 0.326841 NCI Vacunas 0.308043 American Cancer Society 0.337456 Epstein-Barr virus with 0.308914 Epstein-Barr virus 0.318034 Cancer Statistics 0.318768 Winn DM 0.308575 escamoso metastático 0.312489 case-control studies 0.308924 Cancer Institute State 0.321996 risk factors 0.312336 Brennan P 0.309874 Estados Unidos 0.32769 PubMed Abstract 0.972002 Gillison ML 0.308728 neck cancers 0.463711 Leclerc A 0.308319 patients with 0.31588 Cancer Epidemiology 0.478301 epstein-barr virus dna 0.30801 Boffetta P 0.327923 Chuang SC 0.308139 Cancer Epidemiology Consortium 0.352034 Cancer Journal 0.322016	International Journal 0.329442 Schottenfeld D 0.32536 upper aerodigestive tract 0.317554 second primary tumors 0.315336 United States 0.307873 neck squamous 0.307836 Fraumeni JF Jr 0.348613 International Head 0.313722 Nasopharyngeal Cancer 0.321339 occupational exposure 0.308922 National Cancer Institute 0.392376 Cancer Research 0.332513 Oxford University 0.322621 New York 0.321319 Yuan JM 0.308767 Epstein-Barr virus infection 0.308137 nasopharyngeal carcinoma 0.309899 international case-control study 0.316625 cáncer del nci 0.316951 Neck Surgery 0.30769 pooled analysis 0.329801 Clinical Cancer Research 0.320259 Habitual risk factors 0.308377 Cancer Biology 0.320747	CLICK HERE
15642	National Cancer Institute	Html	en	Introduction to the Grants Process	Information about the NCI grants process, including recipient eligibility, the different people involved, and information about funding.	Grant section 0.330468 Grants Management Officer 0.557994 business management aspects 0.330645 Revision /Administrative Supplement 0.292103 ongoing extramural activity 0.334159 individual collaborates 0.230568 visit nci 0.417726 legally binding document 0.294148 grant type 0.376998 Application Development 0.390783 funding opportunity announcements 0.296925 particular grant program 0.476454 Research grant funds 0.454642 federal financial assistance 0.312865 scientific research projects 0.381722 additional history 0.228572 Name-Change Agreements 0.225495 cooperative agreement 0.324362 Federal funding limits 0.287544 cancer research services 0.337764 scientific aims 0.238931 recipient organizations 0.237533 NIH organizational component 0.335362 cooperative agreements 0.410646	scientific responsibility 0.224818 basic information 0.22908 Program Announcement 0.22809 clinical research 0.242867 grant application submissions 0.45483 Institutional Business Official 0.318274 grant award 0.34942 important process 0.252274 extramural scientists/clinicians 0.245811 grant application types 0.455543 recipient organization officials 0.350637 NCI Program Directors/Program 0.52301 Grants Management Specialists 0.412374 NCI Grants Management 0.594717 NCI grants process 0.906594 Program Announcements 0.289703 research organization 0.254758 Grants.gov Authorized Organizational 0.310309 cancer care delivery 0.312355 grant portfolio 0.3628 NCI grants program 0.607154 extramural program 0.270142 application process 0.236143 Recipient Institution/Organization 0.256421	CLICK HERE
17190	National Cancer Institute	Html	en	Fertility Issues in Girls and Women with Cancer	Fertility issues are common in women getting cancer treatment. Fertility preservation options include egg freezing, embryo freezing, ovarian tissue freezing, ovarian shielding and ovarian transposition. Resources, support, and clinical trials are listed.	Sexual Health Issues 0.49945 cancer treatment 0.631654 fertility 0.901077 fertility option 0.589889 baseline fertility 0.607588 primary ovarian insufficiency 0.602729 health care team 0.580901 fertility problems 0.587938 stem cell transplants 0.556421 Child Health 0.492531 upsetting long-term effects 0.489052 nearby lymph nodes 0.481626 Bone marrow transplants 0.488319 fertility clinic 0.591948 nearby reproductive organs 0.498052 professionally led support 0.48644 fertility options 0.611153 Egg freezing 0.48771 female cancer patients 0.5846 radiation therapy 0.529983 hot flashes 0.502166 body receiving radiation 0.494041 menstrual periods 0.491262 vaginal dryness 0.507499 early-stage cervical cancer 0.50324	cancer treatments 0.607491 night sweats 0.503968 young female cancer 0.581679 ovaries 0.50886 embryo freezing 0.490634 blood stem cell 0.486791 personal health factors 0.498007 fertility return 0.579732 fertility preservation options 0.694907 fertility preservation 0.7168 ovarian shielding 0.508485 National Institute 0.498573 fertility risks 0.557024 Human Development 0.498529 Reproductive medical information 0.494403 LIVESTRONG Fertility 0.567758 fertility specialist 0.619863 Ovarian tissue freezing 0.511454 cancer 0.694555 fertility preservation clinic 0.610485 fertility preservation discounts 0.595763 ovarian tissue 0.520736 ovarian tissue cryopreservation 0.503109 nearby reproductive tissues 0.497596	CLICK HERE
17285	National Cancer Institute	Html	en	Cognitive Impairment in Adults with Non?Central Nervous System Cancers (PDQ®)–Health Professional Version	Expert-reviewed information summary about cognitive impairment in cancer patients versus normal cognition, and interventions to manage cognition changes	baseline cognitive reserve 0.507261 Cognitive changes 0.487133 adjuvant chemotherapy 0.565287 cancer treatment 0.487264 female breast cancer 0.505802 healthy control subjects 0.489493 Evidence-based cognitive rehabilitation 0.50091 Primary Breast Cancer 0.514885 Advanced cognitive training 0.507364 Clin Breast Cancer 0.579754 cognitive disturbance 0.483538 therapy-related cognitive deficits 0.504332 Eur J Cancer 0.484911 early-stage breast cancer 0.528107 cognitive dysfunction 0.521546 Von Ah 0.50591 cognitive function 0.609612 cancer-related cognitive impairment 0.500166 cognitive problems. 0.495567 breast cancer patients 0.582272 cancer patients 0.586019 elderly cancer patients 0.495074 cognitive functioning 0.510209 breast cancer survivors 0.779751 self-reported cognitive complaints 0.520137	cancer survivors 0.787075 cancer chemotherapy 0.497699 et al. 0.681052 psychosocial cancer rehabilitation 0.489752 colorectal cancer survivors 0.495325 cognitive rehabilitation 0.534264 PUBMED Abstract 0.565725 Support Care Cancer 0.521007 chemotherapy-treated breast cancer 0.517795 self-reported cognitive dysfunction 0.498525 experience cognitive problems 0.520232 cognitive impairment. 0.494247 Abstract 0.636513 Clin Oncol 0.48687 breast cancer 0.95028 group cognitive rehabilitation 0.514826 elderly cancer survivors 0.500464 randomized controlled trial 0.590229 Cognitive rehabilitation group 0.513937 treatment-related cognitive impairment 0.499304 brain tumor patients 0.525127 chemotherapy-related cognitive change 0.538912 cognitive impairment 0.555272 self-reported cognitive problems 0.505428	CLICK HERE